PTCT
Ptc Therapeutics, Inc.
$34.16
Earnings Summary
Revenue | $307.06Mn |
Net Profits | $-155.79Mn |
Net Profit Margins | -50.74% |
Highlights
Ptc Therapeutics, Inc.’s revenue jumped 83.41% since last year same period to $307.06Mn in the Q4 2023. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 56.2% jump in its revenue since last 3-months.
Ptc Therapeutics, Inc.’s net profit jumped 8.83% since last year same period to $-155.79Mn in the Q4 2023. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -17.16% fall in its net profits since last 3-months.
Ptc Therapeutics, Inc.’s net profit margin jumped 50.3% since last year same period to -50.74% in the Q4 2023. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 24.99% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ptc Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -1.24 |
EPS Estimate Current Year | -1.24 |
Highlights
Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.24 - a -348% fall from last quarter’s estimates.
Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.24.
Key Ratios
Key ratios of the Ptc Therapeutics, Inc. post its Q1 2024 earnings
Earning Per Share (EPS) | -1.2 |
Highlights
Ptc Therapeutics, Inc.’s earning per share (EPS) jumped 36.17% since last year same period to -1.2 in the Q1 2024. This indicates that the Ptc Therapeutics, Inc. has generated 36.17% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-06-05 | -1.24 | -1.2 | 3.23% |
₹0 US Stocks a/c Opening Fee